Evidence map›Paper›PMID 36733761›Full record

ArticleBiomedical optics express2022

In vivo monitoring of vascularization and oxygenation of tumor xenografts using optoacoustic microscopy and diffuse optical spectroscopy.

K G Akhmedzhanova, A A Kurnikov, D A Khochenkov, Yu A Khochenkova, A M Glyavina, V V Kazakov, A V Yudintsev, A V Maslennikova, I V Turchin, P V Subochev and 1 more

Abstract read
In one paragraph

Article in Biomedical optics express, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

K G AkhmedzhanovaInstitute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia.
A A KurnikovInstitute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia.ORCID https://orcid.org/0000-0003-2121-2101
D A KhochenkovN.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.
Yu A KhochenkovaN.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.
A M GlyavinaInstitute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia.
V V KazakovInstitute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia.
A V YudintsevLobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
A V MaslennikovaInstitute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia.
I V TurchinInstitute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia.
P V SubochevInstitute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia.
A G OrlovaInstitute of Applied Physics, Russian Academy of Sciences, Nizhny Novgorod, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The research is devoted to comparison of the blood vessel structure and the oxygen state of three xenografts: SN-12C, HCT-116 and Colo320. Differences in the vessel formation and the level of oxygenation are revealed by optoacoustic (OA) microscopy and diffuse optical spectroscopy (DOS) respectively. The Colo320 tumor is characterized by the highest values of vessel size and fraction. DOS showed increased content of deoxyhemoglobin that led to reduction of saturation level for Colo320 as compared to other tumors. Immunohistochemical (IHC) analysis for CD31 demonstrates the higher number of vessels in Colo320. The IHC for hypoxia was consistent with DOS results and revealed higher values of the relative hypoxic fraction in Colo320.

Identifiers

PMID36733761
PMCPMC9872889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.